# FDA Inspection 1265843 - Rigel Pharmaceuticals Inc - March 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/c0352afe-8df6-46b3-9b8a-9a2b3aee43f9
Source feed: FDA_Inspections

> FDA Inspection 1265843 for Rigel Pharmaceuticals Inc on March 28, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265843
- Company Name: Rigel Pharmaceuticals Inc
- Inspection Date: 2025-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1265843 - 2025-03-28](https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/c57bb907-aedf-4d06-8d8a-20b57fc033d1)
- [FDA Inspection 1191864 - 2022-09-28](https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/a860ea65-407d-4dd8-9751-d4f04d596ba9)
- [FDA Inspection 1028212 - 2017-08-23](https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/a717e2f4-cf6f-4601-9df7-080bbd9b1a26)

Company: https://www.keypedia.com/companies/rigel-pharmaceuticals-inc/d9eb0a68-bb3f-4db0-86ac-6e28322ce2b6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c